Casuarina Equisetifoli
Generic Name: casuarina equisetifoli
Brand Names:
Australian Pine Pollen
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: CASUARINA EQUISETIFOLIA POLLEN (.05 g/mL). Category: BLA.
Overview
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: CASUARINA EQUISETIFOLIA POLLEN (.05 g/mL). Category: BLA.
Dosage
Available as injection for cutaneous, intradermal, subcutaneous use.
Related Medications
Pegfilgrastim-cbqv
pegfilgrastim-cbqv
Leukocyte Growth Factor [EPC]
11 DESCRIPTION Pegfilgrastim-cbqv is a covalent conjugate of recombinant methionyl human G-CSF and monomethoxypolyethylene glycol. Recombinant methionyl human G-CSF is a water-soluble, 175 amino acid protein with a molecular weight of approximately 19 kilodaltons (kDa). Recombinant methionyl human G-CSF is obtained from the bacterial fermentation of a strain of E coli transformed with a genetically engineered plasmid containing the human G-CSF gene.
Pirtobrutinib
pirtobrutinib
Kinase Inhibitor [EPC]
11 DESCRIPTION Pirtobrutinib is a kinase inhibitor. It is an orally available, small molecule ATP-competitive inhibitor of BTK. The active pharmaceutical ingredient is pirtobrutinib with the molecular formula C 22 H 21 F 4 N 5 O 3 and a molecular weight of 479.44 g/mol. The chemical name for pirtobrutinib is 5-amino-3-{4-[(5-fluoro-2-methoxybenzamido)methyl]phenyl}-1-[(2 S )-1,1,1-trifluoropropan-2-yl]-1 H -pyrazole-4-carboxamide.
Loratadine And Pseudoephedrine
loratadine and pseudoephedrine
PURPOSE Antihistamine Nasal decongestant
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.